Early reduction in total cholesterol to high-density lipoprotein cholesterol ratio predicts hydroxychloroquine efficacy in treating IgA nephropathy.
早期降低總膽固醇與高密度脂蛋白膽固醇比率可預測治療 IgA 腎病的 hydroxychloroquine 效能。
Ren Fail 2024-08-30
Clinicopathological Characteristics and Outcomes of Immunoglobulin A Nephropathy with Different Types of Dyslipidemia: A Retrospective Single-Center Study.
免疫球蛋白A腎病不同類型血脂異常的臨床病理特徵及結果:一項單中心回顧性研究。
Kidney Blood Press Res 2024-04-12
The nucleotide-sensing Toll-Like Receptor 9/Toll-Like Receptor 7 system is a potential therapeutic target for IgA nephropathy.
核苷酸感知Toll樣受體9/Toll樣受體7系統是治療IgA腎病的潛在治療靶點。
Kidney Int 2023-10-20
The efficacy and safety of hydroxychloroquine versus leflunomide in patients with IgA nephropathy: a single-center experience.
羥氯喹與來氟米特在IgA腎病患者中的療效和安全性:單一中心經驗。
J Nephrol 2024-01-15
Exploring therapeutic mechanisms of Chuan Huang Fang-II in the treatment of acute kidney injury on chronic kidney disease patients from the perspective of lipidomics.
從脂質組學的角度探討《川黃方-II》在治療慢性腎病患者急性腎損傷中的治療機制。
Ren Fail 2024-05-24
Hydroxychloroquine blood concentrations and effects in Chinese patients with IgA nephropathy.
IgA 腎病患者中 Hydroxychloroquine 血藥濃度及其影響。
J Nephrol 2024-07-24
Efficacy and safety of telitacicept in IgA nephropathy: A retrospective, multicenter study.
Telitacicept 在 IgA 腎病中的療效與安全性:一項回顧性多中心研究。
Nephron 2024-09-09
Hydroxychloroquine as an add-on therapy for the induction therapy of MPO-AAV: a retrospective observational cohort study.
作為MPO-AAV誘導療法的輔助治療,羥氯喹的回顧性觀察性隊列研究。
Clin Kidney J 2024-09-17